ANKRD1 (Ankyrin Repeat Domain 1), also known as CARP (CAncer-related protein) or MCARP (Muscle-specific CARP), is a transcriptional coactivator and scaffold protein containing multiple ankyrin repeat domains. It plays pivotal roles in muscle development, cardiac function, stress responses, and has emerged as an important player in neuronal function and neurodegenerative diseases. ANKRD1 acts as a transcriptional coactivator for p53 and YAP/TAZ, regulating genes involved in cell proliferation, apoptosis, differentiation, and stress responses[1][2]. Its expression is dynamically regulated in response to cellular stress, and mounting evidence implicates ANKRD1 in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and cerebrovascular injury[3][4].
ANKRD1 is a member of the ankyrin repeat family of proteins, characterized by tandem repeats of the ankyrin motif—a 33-amino acid sequence that mediates protein-protein interactions. The protein is expressed in multiple tissues, with highest expression in cardiac muscle, skeletal muscle, and brain. Its dual function as a transcriptional coactivator and scaffold protein allows it to integrate diverse cellular signals and regulate gene expression programs critical for cellular homeostasis and stress responses.
The discovery of ANKRD1's function as a p53 coactivator linked it to the cellular stress response network. Under conditions of cellular stress, including oxidative stress, DNA damage, and oncogenic stress, ANKRD1 is upregulated and cooperates with p53 to activate genes involved in cell cycle arrest, DNA repair, and apoptosis. This positions ANKRD1 as an important node in the cellular decision between survival and cell death.
In the nervous system, ANKRD1 is expressed in neurons throughout the brain, including cortical neurons, hippocampal neurons, and dopaminergic neurons of the substantia nigra. Its functions in transcriptional regulation, stress response, and protein interactions have direct implications for neurodegeneration. Recent studies have revealed that ANKRD1 is upregulated in AD and PD brains and modulates neuronal survival through p53-dependent and independent mechanisms[3:1][5].
The ANKRD1 gene is located on chromosome 10q23.31 and encodes a protein of 319 amino acids. The gene consists of multiple exons and produces alternatively spliced transcripts with tissue-specific expression patterns. The promoter region contains response elements for various transcription factors, including p53, allowing rapid upregulation in response to cellular stress.
ANKRD1 contains several functional domains that mediate its diverse functions:
Ankyrin Repeat Domain:
Nuclear Localization Signals (NLS):
Transactivation Domain:
p53-Binding Region:
YAP/TAZ-Interaction Domain:
ANKRD1 functions primarily as a transcriptional coactivator:
p53 Coactivation:
YAP/TAZ Interaction:
Other Transcription Factors:
ANKRD1 is a key mediator of cellular stress responses:
Oxidative Stress:
DNA Damage:
Mechanical Stress:
Cell Cycle Regulation:
Apoptosis:
In neurons, ANKRD1 serves critical functions:
Transcriptional Regulation:
MAPK Signaling:
Protein Interactions:
ANKRD1 exhibits tissue-specific expression:
Muscle:
Neurons:
Other Tissues:
In neurons, ANKRD1 is predominantly nuclear, consistent with its function as a transcriptional coactivator. However, cytoplasmic localization has been reported, suggesting potential additional functions.
Dilated Cardiomyopathy (DCM):
Hypertrophic Cardiomyopathy:
Heart Failure:
Skeletal Muscle Involvement:
Muscle Regeneration:
Alzheimer's Disease:
Parkinson's Disease:
Stroke and Ischemia:
Oncogenic Role:
Metastasis:
Gene Therapy:
Small Molecule Modulators:
Biomarkers:
Modulating Neuronal Survival:
Therapeutic Strategies:
Targeted Approaches:
Key experimental approaches for studying ANKRD1 include:
Zhang et al. CARP acts as a coactivator for p53 in stress response and cancer. Cell Death & Disease. 2018. ↩︎ ↩︎
Miller et al. ANKRD1 and the p53 tumor suppressor pathway. Journal of Molecular Cell Biology. 2013. ↩︎ ↩︎
Kim et al. ANKRD1 in neurodegeneration and neuronal stress response. Neurobiology of Aging. 2022. ↩︎ ↩︎ ↩︎
Zou et al. ANKRD1 modulates MAPK signaling in neuronal cells. Journal of Neurochemistry. 2021. ↩︎ ↩︎
Liu et al. ANKRD1 in Parkinson's disease models. Redox Biology. 2020. ↩︎ ↩︎
Chen et al. ANKRD1 in oxidative stress and cellular apoptosis. Free Radical Biology & Medicine. 2019. ↩︎ ↩︎
Yang et al. ANKRD1 in autophagy and protein quality control. Autophagy. 2017. ↩︎
Wang et al. ANKRD1 variants in dilated cardiomyopathy. Journal of the American College of Cardiology. 2020. ↩︎
Park et al. ANKRD1 as a biomarker for cardiac injury. Circulation Research. 2018. ↩︎
Shen et al. ANKRD1 in muscular dystrophy and muscle regeneration. Skeletal Muscle. 2020. ↩︎
Nguyen et al. ANKRD1 and muscle satellite cell function. Stem Cell Reports. 2019. ↩︎
Zhou et al. ANKRD1 knockdown in neuronal models of Alzheimer's disease. Molecular Neurobiology. 2019. ↩︎
Liu et al. ANKRD1 in cerebral ischemia and stroke. Stroke. 2018. ↩︎
Song et al. ANKRD1 in cancer progression and metastasis. Oncotarget. 2018. ↩︎